Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andreas Mock

Showing results (51-60 of 67) with videos related to

Pageof 7
Sort By:
Nature Communications|May 10, 2020
The landscape of chromothripsis across adult cancer typesNatalia Voronina, John K L Wong, Daniel Hübschmann, et al.
Acta Neuropathologica|May 2, 2015
Molecular profiling of long-term survivors identifies a subgroup of glioblastoma characterized by chromosome 19/20 co-gainChristoph Geisenberger, Andreas Mock, Rolf Warta, et al.
Targeted Oncology|August 18, 2023
A Retrospective Analysis of Biliary Tract Cancer Patients Presented to the Molecular Tumor Board at the Comprehensive Cancer Center MunichDanmei Zhang, Klara Dorman, Kathrin Heinrich, et al.
Journal for Immunotherapy of Cancer|March 16, 2022
MEK1/2 inhibition transiently alters the tumor immune microenvironment to enhance immunotherapy efficacy against head and neck cancerManu Prasad, Jonathan Zorea, Sankar Jagadeeshan, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|August 21, 2024
Lymphotoxin beta-activated LTBR/NIK/RELB axis drives proliferation in cholangiocarcinomaKaiyu Xu, Annika Kessler, Federico Nichetti, et al.
NPJ Precision Oncology|October 26, 2023
NCT/DKFZ MASTER handbook of interpreting whole-genome, transcriptome, and methylome data for precision oncologyAndreas Mock, Maria-Veronica Teleanu, Simon Kreutzfeldt, et al.
Cell Death & Disease|October 18, 2020
Identification of BCL-XL as highly active survival factor and promising therapeutic target in colorectal cancerAnna-Lena Scherr, Andreas Mock, Georg Gdynia, et al.
Med (New York, N.Y.)|May 1, 2026
Clinically actionable genomic and transcriptomic landscape of advanced neuroendocrine neoplasmsSimon Kreutzfeldt, Leonidas Apostolidis, Małgorzata Oleś, et al.
Acta Neuropathologica|October 3, 2020
Patient-derived organoids and orthotopic xenografts of primary and recurrent gliomas represent relevant patient avatars for precision oncologyAnna Golebiewska, Ann-Christin Hau, Anaïs Oudin, et al.
Nature Communications|August 2, 2022
Comprehensive genomic and epigenomic analysis in cancer of unknown primary guides molecularly-informed therapies despite heterogeneityLino Möhrmann, Maximilian Werner, Małgorzata Oleś, et al.
Pageof 7

Showing results (51-60 of 67) with videos related to

Sort By:
Pageof 7
Nature Communications|May 10, 2020
The landscape of chromothripsis across adult cancer typesNatalia Voronina, John K L Wong, Daniel Hübschmann, et al.
Acta Neuropathologica|May 2, 2015
Molecular profiling of long-term survivors identifies a subgroup of glioblastoma characterized by chromosome 19/20 co-gainChristoph Geisenberger, Andreas Mock, Rolf Warta, et al.
Targeted Oncology|August 18, 2023
A Retrospective Analysis of Biliary Tract Cancer Patients Presented to the Molecular Tumor Board at the Comprehensive Cancer Center MunichDanmei Zhang, Klara Dorman, Kathrin Heinrich, et al.
Journal for Immunotherapy of Cancer|March 16, 2022
MEK1/2 inhibition transiently alters the tumor immune microenvironment to enhance immunotherapy efficacy against head and neck cancerManu Prasad, Jonathan Zorea, Sankar Jagadeeshan, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|August 21, 2024
Lymphotoxin beta-activated LTBR/NIK/RELB axis drives proliferation in cholangiocarcinomaKaiyu Xu, Annika Kessler, Federico Nichetti, et al.
NPJ Precision Oncology|October 26, 2023
NCT/DKFZ MASTER handbook of interpreting whole-genome, transcriptome, and methylome data for precision oncologyAndreas Mock, Maria-Veronica Teleanu, Simon Kreutzfeldt, et al.
Cell Death & Disease|October 18, 2020
Identification of BCL-XL as highly active survival factor and promising therapeutic target in colorectal cancerAnna-Lena Scherr, Andreas Mock, Georg Gdynia, et al.
Med (New York, N.Y.)|May 1, 2026
Clinically actionable genomic and transcriptomic landscape of advanced neuroendocrine neoplasmsSimon Kreutzfeldt, Leonidas Apostolidis, Małgorzata Oleś, et al.
Acta Neuropathologica|October 3, 2020
Patient-derived organoids and orthotopic xenografts of primary and recurrent gliomas represent relevant patient avatars for precision oncologyAnna Golebiewska, Ann-Christin Hau, Anaïs Oudin, et al.
Nature Communications|August 2, 2022
Comprehensive genomic and epigenomic analysis in cancer of unknown primary guides molecularly-informed therapies despite heterogeneityLino Möhrmann, Maximilian Werner, Małgorzata Oleś, et al.
Pageof 7